Hyporamine tablets sublingual 20 mg - instructions for use, dose, side effects, contraindications

Similar drugsTo uncover

Dosage form: & nbspsublingual tablets

Composition:

Composition (per one tablet)

Active substance

Hyporamin ® extract dry (sea buckthorn crushed leaves extract dry) - 0,02 g, with the content of the sum of tannins in terms of casuarinine and absolutely dry matter of 60%

Excipients

Refined sugar (sucrose) - 0.5299 g

cocoa powder (cocoa bean powder) - 0.0200 g

vanillin - 0.0001 g

sodium carboxymethylcellulose purified (carmellose sodium) - 0.0240 g

calcium stearate - 0.0060 g

Tablet weight -0.6 g

Description:

Tablets round shape ploskotsilindricheskoy scored on one side and a facet on both sides, from light gray or light gray color with a tinge of pink to light brown in color with light and dark patches.

Pharmacotherapeutic group:An antiviral agent of plant origin

ATX: & nbsp

Other antiviral drugs

Pharmacodynamics:

Hyporamin ® - dry, purified extract from the sea buckthorn leaves of buckthorn (Hippophae rhamnoides L.) family fur (Elaeagnaceae), which is a polyphenolic complex of galloellaglantins, the biologically active components of which are hydrolysable tannins, having common structural elements in the form of glucosogalloyl and hexahydroxyfenoyl residues.

Hyporamin® has high antiviral activity against various strains of influenza A and B viruses, adenoviruses, paramyxoviruses, herpes simplex viruses, herpes zoster, cytomegalovirus (CMV), respiratory syncytial virus (PCvirus), human immunodeficiency virus (HIV infection). The inhibitory effect of the drug on the reproduction of viruses is manifested in the early stages of their development. One of the mechanisms of action of the drug is the inhibitory effect on viral neuraminidase.

Hyporamin® induces production of interferon in blood cells in experiments in vitro and increases the content of interferon in the blood of patients.

The drug was tested in vitro has also a moderate antimicrobial effect against Gram-positive (Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli, Proteus vulgaris, Pseudomonas aeruginosa), tuberculous mycobacteria (Mycobacterium tuberculosis), candida (Candida albicans) and some mycelial fungi (Microsporum canis).

Hyporamin ® is low toxic. It does not have allergic, immunotoxic, mutagenic, teratogenic and carcinogenic properties.

Indications:

Hyporamin ® is used in adults and children as a therapeutic and prophylactic for influenza (A and B), parainfluenza, PC-viral, adenoviral and other acute respiratory viral infections; angina, taking place against the background of acute respiratory viral diseases (complex therapy); with acute and recurrent forms of herpes simplex extragenital and genital localization, with shingles, chicken pox and CMV infection.

Contraindications:

Hypersensitivity to the components of the drug. Children's age is up to 3 years (taking into account the solid dosage form of the pill). Deficiency of sugar / isomaltase, intolerance to fructose, glucose-galactose malabsorption.

Carefully:Diabetes.

Pregnancy and lactation:

During pregnancy and breastfeeding, the drug is possible if the intended benefit to the mother exceeds the potential risk to the fetus and the baby.

Dosing and Administration:

Treatment. Hyporamin ® tablets sublingual for 1 tablet (20 mg) are kept in the mouth until they are fully resorbed. Adults and children over 12 years of age are prescribed 1 tablet (20 mg) 4-6 times a day, children 6-12 years - 1 tablet (20 mg) 3-4 times a day, children 3-6 years - according to 1/2 tablets (10 mg) 2-4 times a day.

Duration of use from 3 days to 3 weeks, depending on the nosological form of the disease. At a flu - not less than 3 days; with parainfluenza, PC-viral, adenoviral infections, angina that occur against the background of acute respiratory viral diseases (complex therapy), and other SARS - at least 5 days.

With chicken pox, shingles, herpesvirus and CMV infections duration of application depends on the severity of the process and is 3-10 days for mild forms of the disease. In severe and relapsing forms of the disease, the minimum course of treatment is 2-3 weeks. Repeated courses of treatment are advisable.

For prophylaxis during the outbreak of influenza Hyporamin®, sublingual tablets are taken in accordance with age dosages from 3 days to 3 weeks.

As a prophylactic for the prevention of the development of viral complications (herpesvirus diseases and CMV infection) in conditions of immunosuppressive therapy in postoperative patients, in the risk groups Hyporamin® in the form of sublingual tablets (20 mg) is used 3 times a day for 5-7 days.

Side effects:Allergic reactions are possible.

Overdose:

To date, cases of drug overdose have not been reported.

With prolonged use in doses exceeding those specified in the instructions, it is possible to increase coagulability of the blood.

Treatment: symptomatic.

Interaction:

It is possible to use the drug in combination with other drugs (antimicrobial agents, synthetic antiviral agents, means for symptomatic therapy).

Special instructions:

Hyporamin ® is prescribed at the earliest possible time of the disease. The most pronounced therapeutic effect is achieved by combining the medicinal forms of the drug with generalized and local action (suppositories rectal and / or vaginal with hyporamine 0.05 g (for adults), ointment for topical and topical application 0.5%, hypophamine lyophilized for solutions 0, 02 g in the form of an aqueous solution-a drop in the nose, inhalation).

1 tablet contains 0.5539 grams of carbohydrates, which corresponds to 0.046 XE.

Patients with diabetes should take the drug after consultation with a doctor.

Children from 2 months to 3 years of age are prescribed a hypophamine lyophilized for solutions

0.02 g in the form of an aqueous solution-a drop in the nose, inhalation.

Effect on the ability to drive transp. cf. and fur:The drug has no effect on the performance of potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions (including managementvehicles, work with moving mechanisms).

Form release / dosage:Tablets of sublingual 20 mg.

Packaging:

For 10, 20 or 30 tablets per contour cell packaging made of polyvinylchloride film and aluminum foil printed with a thermo-lacquer coating.

1, 2, 3 or 5 contiguous cell packs of 10 tablets or 1 circuit cell pack of 20 tablets or 30 tablets together with instructions for medical use are placed in a pack of cardboard for consumer containers.

Storage conditions:

In a dry, protected from light place at a temperature of no higher than 25 ° C. Keep out of the reach of children.

Shelf life:

4 years. Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:PL-000619

Date of registration:21.09.2011

The owner of the registration certificate:FARMTSENTR VILAR, ZAO FARMTSENTR VILAR, ZAO Russia

Manufacturer: & nbsp

FARMTSENTR VILAR, ZAO Russia

Information update date: & nbsp23.10.2015

Illustrated instructions

Instructions

Hyporamin ® tablets sublingual 20 mg (Hiporhamin® tablets sublingual 20 mg)